This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Our team conducted a review of all of the biotech mergers and acquisitions of 2021 and distilled it down to…
Article
10 months ago ●
12 mins read
Toward CTPS1 inhibitors as a safer alternative to nucleoside chemotherapeutics: Rapidly growing cancer cells are critically dependent on synthesis of…
molecule
3 months ago ●
3 mins read
There were 16 acquisitions of companies with small molecule drug assets in 2021 and one merger. Here is a more…
Article
10 months ago ●
18 mins read
Revisiting AMPK activation with β2-AMPK isoform potency. “Compound 14d” (Shionogi & Co.) is a highly potent, dose-dependent adenosine monophosphate activated…
molecule
3 months ago ●
4 mins read
There were two novel small molecules approved in May 2022: vonoprazan (Voquezna): a potassium-competitive acid blocker (PCAB) tapinarof (Vtama): an…
Article
10 months ago ●
13 mins read
sAC as a target for male contraception. Soluble adenylyl cyclase (sAC) is one of several ACs that catalyze the cyclization…
molecule
3 months ago ●
4 mins read
Load More
